Clinicopathologic and Molecular Characterization of Four Cases of Pediatric Salivary Secretory Carcinoma (SSC), One with ETV6-RET Fusion
- 18 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Head and Neck Pathology
- Vol. 15 (3), 796-802
- https://doi.org/10.1007/s12105-021-01288-7
Abstract
Salivary gland secretory carcinoma (SSC) is a neoplasm with characteristic histologic features, similar to those of secretory carcinoma of the breast. Only a few pediatric SSC cases have been reported, all with ETV6-NTRK3 fusion. We present four new pediatric SSC examples, one with a novel ETV6-RET fusion. Four cases of SSC were diagnosed between 2010 and 2020: 2 boys, 7 and 9 year-old with parotid tumors (1.5 and 1.3 cm, respectively); and two 14 year-old girls: one with a submandibular tumor (2.1 cm), and one with a parotid lesion (1.2 cm). Histologically, all tumors were similar: well-circumscribed lesions composed by mid-size, monotonous cells with eosinophilic and sometimes vacuolated cytoplasm. The nuclei are oval to round with open chromatin and a single nucleolus. There are duct-like structures and microcysts with colloid-like material. Immunohistochemically, tumor cells are positive for S100, CK7, mammaglobin and GATA3. A classic ETV6-NTRK3 translocation was confirmed in the three parotid tumors; an ETV6-RET fusion was demonstrated in the submandibular lesion. All patients underwent complete surgical resection and are alive without tumor recurrence after a follow-up time ranging from one to 4 years. Pediatric SSC is extremely rare but their characteristic morphology and immunohphenotype facilitate their diagnosis. We describe the first pediatric case with the recently reported ETV6-RET fusion. Similar to adult cases, this tumor is morphologically undistinguishable from those carrying the classic ETV6–NTRK3 translocation. Thus, in pediatric cases with morphology suggestive of SSC and negative ETV6-NTRK3 by RT-PCR, other possible fusions should be investigated.Keywords
Funding Information
- Marjory K. Harmer Endowment for Research in Pediatric Pathology
This publication has 29 references indexed in Scilit:
- Characterization of mammary analogue secretory carcinoma of the salivary gland: discrimination from its mimics by the presence of the ETV6-NTRK3 translocation and novel surrogate markersHuman Pathology, 2014
- A rare malignancy of the parotid gland in a 13-year-old Taiwanese boy: case report of a mammary analogue secretory carcinoma of the salivary gland with molecular studyMedical Molecular Morphology, 2013
- Mammary Analogue Secretory Carcinoma of the Parotid Gland as a Secondary Malignancy in a Childhood Survivor of Atypical Teratoid Rhabdoid TumorHead and Neck Pathology, 2013
- Mammary Analogue Secretory Carcinoma of the Parotid Gland in a Pediatric PatientOtolaryngology -- Head and Neck Surgery, 2011
- Mammary analogue secretory carcinoma: a new twist to the diagnostic dilemma of zymogen granule poor acinic cell carcinomaVirchows Archiv A Pathological Anatomy and Histopathology, 2011
- Mammary Analogue Secretory Carcinoma of Salivary Glands, Containing the ETV6-NTRK3 Fusion Gene: A Hitherto Undescribed Salivary Gland Tumor EntityThe American Journal of Surgical Pathology, 2010
- ETV6–NTRK3: a chimeric protein tyrosine kinase with transformation activity in multiple cell lineagesSeminars in Cancer Biology, 2005
- ETV6-NTRK3—Trk-ing the primary event in human secretory breast cancerCancer Cell, 2002
- Congenital Mesoblastic Nephroma t(12;15) Is Associated withETV6-NTRK3 Gene Fusion: Cytogenetic and Molecular Relationship to Congenital (Infantile) FibrosarcomaThe American Journal of Pathology, 1998
- A novel ETV6-NTRK3 gene fusion in congenital fibrosarcomaNature Genetics, 1998